-
As is customary, FDA stayed its approval of the ANDAs for 30 months once Solvay filed suit.
FORBES: FTC Orders Merged Drug Companies Not to Do "Pay-for-Delay" Settlements
-
Solvay continued to reap huge profits by keeping its monopoly in the market.
CNN: How Big Pharma rips you off on drugs
-
In September 2006, Solvay settled the patent litigation with the defendants, entering into business promotional agreements with both generics.
FORBES: FTC Orders Merged Drug Companies Not to Do "Pay-for-Delay" Settlements
-
The next day's summit, on a Thursday, was scheduled for 10:15 a.m. at the Bibliotheque Solvay, a historic library on a Brussels hilltop.
WSJ: EU Set a Secret Group to Save the Euro
-
Critics of the deal say that it's more about financial engineering than drug development. (See " Abbott's Solvay Deal: Don't Get Too Excited").
FORBES: Magazine Article
-
In the pharmaceutical business, the company committed to several purchases in the past like Solvay and Piramal to diversify its portfolio and expand into emerging markets.
FORBES: Abbott Labs Snapshot As AbbVie Begins Trading
-
In the case before the court, Solvay Pharmaceuticals is accused of paying off would-be generic manufacturers of their blockbuster drug AndroGel, a synthetic testosterone used by hundreds of thousands of AIDS patients, cancer patients, elderly men and others who suffer from low levels of testosterone.
CNN: How Big Pharma rips you off on drugs